# Martin Luther King, Jr. Family Clinic, Inc.

Health Center, TX
Page: https://astrelis.co/providers/health_center/451816  
This twin: https://astrelis.co/providers/health_center/451816.md  
CMS Certification Number (CCN): 451816  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 7,755. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -103.8%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 3. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 33.9%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $5.2M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +10.4%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Martin Luther King, Jr. Family Clinic D/B/A Foremost Family Health, TX

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state (FACLAND tier 1)).

- FY ending 2024-11-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-11-GSAFAC-0000379887
- FY ending 2023-11-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-11-GSAFAC-0000064672
- FY ending 2022-11-30 (audit year 2022): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2022-11-CENSUS-0000105561

| Line | FY ending 2024-11-30 | FY ending 2023-11-30 | FY ending 2022-11-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 420,554 [derived, p.6] | 334,527 [derived, p.6] | 2,024,381 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 170,140 [derived, p.6] | 379,749 [derived, p.6] | 441,527 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 332,284 [derived, p.6] | 428,097 [derived, p.6] | 404,778 [derived, p.6] |
| other current assets (Statement of financial position) | 413,040 [derived, p.6] | 374,816 [derived, p.6] | 167,887 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 1,336,018 [extracted, p.6] | 1,517,189 [extracted, p.6] | 3,038,573 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 530,605 [derived, p.6] | 275,221 [derived, p.6] | 398,060 [derived, p.6] |
| other long-term assets (Statement of financial position) | 537,386 [derived, p.6] | 733,041 [derived, p.6] | absent (not printed, or not read) |
| TOTAL ASSETS (Statement of financial position) | 2,404,009 [extracted, p.6] | 2,525,451 [extracted, p.6] | 3,436,633 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 802,950 [derived, p.6] | 1,144,068 [derived, p.6] | 936,753 [derived, p.6] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | 23,918 [derived, p.6] | 1,522 [derived, p.6] |
| current debt and leases (Statement of financial position) | 188,954 [derived, p.6] | 206,667 [derived, p.6] | absent (not printed, or not read) |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 991,904 [extracted, p.6] | 1,374,653 [extracted, p.6] | 938,275 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 419,962 [derived, p.6] | 606,181 [derived, p.6] | absent (not printed, or not read) |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 80,783 [derived, p.6] |
| TOTAL LIABILITIES (Statement of financial position) | 1,411,866 [extracted, p.6] | 1,980,834 [extracted, p.6] | 1,019,058 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 639,866 [derived, p.6] | 544,617 [derived, p.6] | 2,417,575 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 352,277 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 992,143 [extracted, p.6] | 544,617 [extracted, p.6] | 2,417,575 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 4,291,901 [derived, p.7] | 5,164,333 [derived, p.7] | 4,514,124 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | 5,252,552 [derived, p.7] | 5,426,811 [derived, p.7] | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 134,391 [derived, p.7] | 20,410 [derived, p.7] | 6,828,989 [derived, p.7] |
| contributions (Statement of activities) | 675,075 [derived, p.7] | 463,450 [derived, p.7] | 319,439 [derived, p.7] |
| other revenue (Statement of activities) | 158,885 [derived, p.7] | 180,015 [derived, p.7] | 157,465 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 10,512,804 [extracted, p.7] | 11,255,019 [extracted, p.7] | 11,820,017 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 7,055,135 [derived, p.7] | 8,540,807 [derived, p.7] | 7,468,641 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 424,913 [derived, p.7] | 666,505 [derived, p.7] | 2,144,320 [derived, p.7] |
| purchased and professional services (Statement of activities) | 965,789 [derived, p.7] | 1,501,460 [derived, p.7] | 1,593,307 [derived, p.7] |
| occupancy (Statement of activities) | 640,303 [derived, p.7] | 689,743 [derived, p.7] | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | 102,093 [derived, p.7] | 154,898 [derived, p.7] | 165,425 [derived, p.7] |
| interest (Statement of activities) | absent (not printed, or not read) | 6,278 [derived, p.7] | absent (not printed, or not read) |
| other expenses (Statement of activities) | 1,229,580 [derived, p.7] | 1,569,506 [derived, p.7] | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 10,417,813 [extracted, p.7] | 13,129,197 [extracted, p.7] | 11,371,693 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | 94,991 [extracted, p.7] | -1,874,178 [extracted, p.7] | 448,324 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 352,535 [derived] | 1,220 [derived, p.7] | 708 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | 447,526 [extracted, p.8] | -1,872,958 [extracted, p.7] | 449,032 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 544,617 [extracted, p.8] | 2,417,575 [extracted, p.7] | 1,968,543 [extracted, p.7] |
| net assets, end (Statement of activities) | 992,143 [extracted, p.8] | 544,617 [extracted, p.7] | 2,417,575 [extracted, p.7] |

| Ratio | FY ending 2024-11-30 | FY ending 2023-11-30 | FY ending 2022-11-30 |
|---|---:|---:|---:|
| Days cash on hand | 15 days [plausible] | 9 days [plausible] | 66 days [plausible] |
| Current ratio | 1.35x [plausible] | 1.10x [plausible] | 3.24x [plausible] |
| Operating margin | 0.9% [plausible] | -16.7% [plausible] | 3.8% [plausible] |
| Total margin | 4.3% [plausible] | -16.6% [plausible] | 3.8% [plausible] |
| Patient revenue share | 40.8% [plausible] | 45.9% [plausible] | 38.2% [plausible] |
| Grant dependency | 51.2% [plausible] | 48.4% [plausible] | absent [not computed] |
| Salaries share | 67.7% [plausible] | 65.1% [plausible] | 65.7% [plausible] |
| Days in patient receivables | 15 days [plausible] | 27 days [plausible] | 36 days [plausible] |
| Debt to net assets | 0.61x [plausible] | 1.49x [plausible] | absent [not computed] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Martin Luther King, Jr. Family Clinic D/B/A Foremost Family Health; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Martin Luther King, Jr. Family Clinic, Inc.", https://astrelis.co/providers/health_center/451816, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.